Angstrom6

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAngstrom6
Drug Alias NameA6 peptideAngstrom 6A6
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAngstrom
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesÅngstrom PharmaceuticalsNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A